These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11694000)

  • 1. Increased absorption of zinc from alimentary tract in primary arterial hypertension.
    Tubek S
    Biol Trace Elem Res; 2001 Oct; 83(1):31-8. PubMed ID: 11694000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary zinc excretion is normalized in primary arterial hypertension after perindopril treatment.
    Tubek S
    Biol Trace Elem Res; 2006; 114(1-3):127-33. PubMed ID: 17205995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc content in lymphocytes and the activity of zinc ion efflux from lymphocytes in primary arterial hypertension.
    Tubek S
    Biol Trace Elem Res; 2005 Nov; 107(2):89-99. PubMed ID: 16217134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study.
    Koren-Michowitz M; Dishy V; Zaidenstein R; Yona O; Berman S; Weissgarten J; Golik A
    Am J Hypertens; 2005 Mar; 18(3):358-63. PubMed ID: 15797654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of valsartan and perindopril in the treatment of essential hypertension in the malaysian population.
    Bavanandan S; Morad Z; Ismail O; Chandran A; Thayaparan T; Singaraveloo M
    Med J Malaysia; 2005 Jun; 60(2):158-62. PubMed ID: 16114156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renoprotection persists after cessation of treatment with very low doses of perindopril in Lyon hypertensive rats.
    Egan EJ; Dijoud F; Gilibert S; Sassard J
    Acta Pharmacol Sin; 2008 Nov; 29(11):1296-300. PubMed ID: 18954523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
    J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of perindopril's efficacy on arterial distensibility in mild to moderate hypertension.
    J Med Assoc Thai; 2001 Jul; 84(7):1006-14. PubMed ID: 11759959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].
    Toblli JE; Bellido CA; Iavícoli OR; Costa M; Forcada P; Piñeiro DJ; Lerman J
    Medicina (B Aires); 2002; 62(6):544-50. PubMed ID: 12532688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.
    Rehman A; Ismail SB; Naing L; Roshan TM; Rahman AR
    Am J Hypertens; 2007 Feb; 20(2):184-9. PubMed ID: 17261465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in selected zinc metabolism parameters in obese and normal-weight hypertensive patients following treatment with spironolactone.
    Tubek S
    Biol Trace Elem Res; 2006; 114(1-3):135-41. PubMed ID: 17205996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.